1. Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. Issue 10274 (13th February 2021) Authors: Langley, Ruth E; Gilbert, Duncan C; Duong, Trinh; Clarke, Noel W; Nankivell, Matthew; Rosen, Stuart D; Mangar, Stephen; Macnair, Archie; Sundaram, Subramanian Kanaga; Laniado, Marc E; Dixit, Sanjay; Madaan, Sanjeev; Manetta, Caroline; Pope, Alvan; Scrase, Christopher D; Mckay, Stephen; Muazzam, I... Journal: Lancet Issue: Volume 397:Issue 10274(2021) Page Start: 581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗